Impact of Next-Generation Flow (NGF) Minimal Residual Disease (MRD) Monitoring in Multiple Myeloma (MM): Results from the Pethema/GEM2012 Trial

被引：0
作者：
Paiva, Bruno
Puig, Noemi
Cedena, Maria Teresa
Cordon, Lourdes
Vidriales, Maria-Belen
Burgos, Leire
Flores-Montero, Juan
Lopez-Anglada, Lucia
Gutierrez, Norma
Calasanz, Maria Jose
Martin-Ramos, Maria Luisa
Garcia-Sanz, Ramon
Martinez-Lopez, Joaquin
Oriol, Albert
Blanchard, M. Jesus
Rios, Rafael
Martin, Jesus
Martinez, Rafael
Sarra, Josep
Hernandez, Miguel T.
de la Rubia, Javier
Krsnik, Isabel
Moraleda, Jose M.
Palomera, Luis
Bargay, Juan
Orfao, Alberto
Rosinol, Laura
Mateos, Maria-Victoria
Lahuerta, Juan-Jose
Blade, Joan
San Miguel, Jesus F.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
905
引用
收藏
页数：2
相关论文
共 50 条
[41]   High sensitive immunophenotyping studies for monitoring minimal residual disease (MRD) post-transplant in multiple myeloma (MM) patients. [J].
Almeida, J ;
Orfao, A ;
Mateo, G ;
Ocqueteau, M ;
Corral, M ;
Caballero, MD ;
Vazquez, L ;
Bladé, J ;
Moro, MJ ;
Hernández, J ;
San Miguel, JF .
BONE MARROW TRANSPLANTATION, 1999, 23 :S132-S132
[42]   Minimal Residual Disease Evaluation By Multiparameter Flow Cytometry and Next Generation Sequencing in the Forte Trial for Newly Diagnosed Multiple Myeloma Patients [J].
Oliva, Stefania ;
Genuardi, Elisa ;
Belotti, Angelo ;
Frascione, Pio Manlio Mirko ;
Galli, Monica ;
Capra, Andrea ;
Offidani, Massimo ;
Vozella, Federico ;
Zambello, Renato ;
Auclair, Daniel ;
Siniscalchi, Agostina ;
Yesil, Jennifer ;
Annibali, Ombretta ;
Kirsch, Ilan M. ;
Caltagirone, Simona ;
Jacob, Allison P. ;
Ballanti, Stelvio ;
Palmas, Angelo D. ;
Ledda, Antonio ;
Corradini, Paolo ;
Omede, Paola ;
Cavo, Michele ;
Musto, Pellegrino ;
Boccadoro, Mario ;
Gay, Francesca .
BLOOD, 2019, 134
[43]   MINIMAL RESIDUAL DISEASE (MRD) DETECTION BY NEXT-GENERATION SEQUENCING AND REAL-TIME QUANTITATIVE PCR: A METHODICAL COMPARISON IN ALL, MCL AND MM [J].
Ladetto, M. ;
Brueggemann, M. ;
Monitillo, L. ;
Ferrero, S. ;
Pepin, F. ;
Drandi, D. ;
Palumbo, A. ;
Passera, R. ;
Boccadoro, M. ;
Carlton, V. ;
Trautmann, H. ;
Faham, M. ;
Pott, C. .
HAEMATOLOGICA, 2013, 98 :125-125
[44]   Minimal residual disease (MRD) monitoring by multiparameter flow cytometry (MFC) in newly diagnosed transplant eligible multiple myeloma (MM) patients: Results from the EMN02/HO95 phase 3 trial. [J].
Oliva, Stefania ;
Bruinink, Davine Hofste op ;
RIhova, Lucie ;
Spada, Stefano ;
van der Holt, Bronno ;
Troia, Rossella ;
Gambella, Manuela ;
Pantani, Lucia ;
Grammatico, Sara ;
Gilestro, Milena ;
Offidani, Massimo ;
Ribolla, Rossella ;
Galli, Monica ;
Hajek, Roman ;
Palumbo, Antonio ;
Cava, Michele ;
Omede, Paola ;
van der, Vincent .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[45]   Minimal Residual Disease (MRD) detection by next-generation sequencing and real-time quantitative PCR: A methodical comparison in ALL, MCL and MM [J].
Brueggemann, M. ;
Ladetto, M. ;
Monitillo, L. ;
Ferrero, S. ;
Pepin, F. ;
Drandi, D. ;
Palumbo, A. ;
Boccadero, M. ;
Carlton, V ;
Trautmann, H. ;
Kneba, M. ;
Faham, M. ;
Ritgen, M. ;
Pott, C. .
ONKOLOGIE, 2013, 36 :169-169
[46]   Clinical validation of next-generation sequencing-based clonality assays for minimal residual disease tracking in multiple myeloma [J].
Lin, Chuanming ;
Jian, Qijie ;
Huang, Zoufang ;
Xie, Shuiling ;
Xin, Liuyan ;
Wu, Haiyan ;
Pang, Fei ;
Liao, Changfeng ;
Chen, Yijian .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[47]   Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy [J].
Ferla, Valeria ;
Antonini, Elena ;
Perini, Tommaso ;
Farina, Francesca ;
Masottini, Serena ;
Malato, Simona ;
Marktel, Sarah ;
Stanghellini, Maria Teresa Lupo ;
Tresoldi, Cristina ;
Ciceri, Fabio ;
Marcatti, Magda .
FRONTIERS IN ONCOLOGY, 2022, 12
[48]   Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma: A Comparison With Real-Time Quantitative PCR [J].
Yao, Qiumei ;
Bai, Yinlei ;
Kumar, Shaji ;
Au, Elaine ;
Orfao, Alberto ;
Chim, Chor Sang .
FRONTIERS IN ONCOLOGY, 2021, 10
[49]   The Value of PET/CT Combined with Next-Generation Flowcytometry in Minimal Residual Disease Detection and Prognostic Evaluation of Multiple Myeloma [J].
Du, Jianhua ;
Chen, Miao ;
Huo, Li ;
Zhu, Wenjia ;
Wang, Huijuan ;
Leng, Yun ;
Liu, Shuangjiao ;
Zhuang, Junling .
BLOOD, 2022, 140 :7214-7214
[50]   Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial [J].
Schmitz, Alexander ;
Brondum, Rasmus Froberg ;
Johnsen, Hans Erik ;
Mellqvist, Ulf-Henrik ;
Waage, Anders ;
Gimsing, Peter ;
Bruinink, Davine Hofste Op ;
van der Velden, Vincent ;
van der Holt, Bronno ;
Hansson, Markus ;
Andersen, Niels Frost ;
Frolund, Ulf Christian ;
Helleberg, Carsten ;
Schjesvold, Fredrik H. ;
Ahlberg, Lucia ;
Gulbrandsen, Nina ;
Andreasson, Bjorn ;
Lauri, Birgitta ;
Haukas, Einar ;
Bodker, Julie Stove ;
Roug, Anne Stidsholt ;
Bogsted, Martin ;
Severinsen, Marianne T. ;
Gregersen, Henrik ;
Abildgaard, Niels ;
Sonneveld, Pieter ;
Dybkaer, Karen .
BMC CANCER, 2022, 22 (01)
12345